Logo image
Audiology in the sudden hearing loss clinical trial
Journal article   Peer reviewed

Audiology in the sudden hearing loss clinical trial

Chris Halpin, Helen Shi, Domenic Reda, Patrick J Antonelli, Seilesh Babu, John P Carey, Bruce J Gantz, Joel A Goebel, Paul E Hammerschlag, Jeffrey P Harris, …
Otology & neurotology, Vol.33(6), pp.907-911
08/2012
DOI: 10.1097/MAO.0b013e31825d9a44
PMCID: PMC3400088
PMID: 22805100
url
https://www.ncbi.nlm.nih.gov/pmc/articles/3400088View
Open Access

Abstract

To report the pretreatment and posttreatment population characteristics and the overall stability of the audiologic outcomes found during the Sudden Hearing Loss Clinical Trial (ClinicalTrials.gov: Identifier NCT00097448).
Steroids - administration & dosage Hearing Loss, Sudden - diagnosis Prednisone - administration & dosage Prospective Studies Methylprednisolone - therapeutic use Administration, Oral Humans Treatment Outcome Clinical Trials as Topic Hearing Loss, Sudden - drug therapy Anti-Inflammatory Agents - therapeutic use Anti-Inflammatory Agents - administration & dosage Steroids - therapeutic use Recognition (Psychology) Administration, Topical Research Design Speech Perception Audiometry, Pure-Tone - methods Prednisone - therapeutic use Methylprednisolone - administration & dosage

Details

Metrics

Logo image